Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

247.51
-10.4900-4.07%
Post-market: 246.00-1.5100-0.61%19:54 EDT
Volume:1.63M
Turnover:404.75M
Market Cap:33.02B
PE:44.05
High:256.68
Open:256.68
Low:246.42
Close:258.00
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:0.82
T/O Rate:1.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:24.39
PE(LYR):106.23

Loading ...

U.S. Research Roundup-3m Co, Nike, Primoris Services

Reuters
·
Jun 29

Alnylam Posts Aln-6400 Plasminogen-targeting Rnai Therapy Presentation on Rare Bleeding Disorders

Reuters
·
Jun 26

Komodo Health Expands Strategic Partnership with Alnylam to Scale Marmot AI Analytics Platform

Reuters
·
Jun 25

Oppenheimer Sticks to Their Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
Jun 25

Movement Alert|Alnylam Pharmaceuticals Rises 5.1% in Regular Trading, Trading at $302.29

Market Focus
·
Jun 25

Regeneron Gets FDA, EMA Review of Cemdisiran in Generalized Myasthenia Gravis

Dow Jones
·
Jun 22

Barclays Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)

TIPRANKS
·
Jun 22

RBC Capital Remains a Buy on Alnylam Pharma (ALNY)

TIPRANKS
·
Jun 22

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-06-18

Reuters
·
Jun 18

Does Alnylam’s Generative AI Pact With Inceptive Nucleics Redraw The R&D Bull Case For ALNY?

Simply Wall St.
·
Jun 16

Alnylam to host 10th RNAi Roundtable webcast series on pipeline updates

Reuters
·
Jun 12

Alnylam, Genesis Pharma Expand Commercial Partnership Into 4 Nordic Markets

MT Newswires Live
·
Jun 10

Genesis Pharma: Extended Agreement With Alnylam Pharmaceuticals NOW Includes Denmark, Finland, Norway, and Sweden

THOMSON REUTERS
·
Jun 10

Genesis Pharma Expands Strategic Commercial Partnership With Alnylam Pharmaceuticals for Rnai Therapeutics to Nordic Region

THOMSON REUTERS
·
Jun 10

Alnylam expands GENESIS Pharma commercialization partnership to Nordic markets

Reuters
·
Jun 10

Bloom Energy, Astera Labs, Alnylam, Reddit Could Be Among Next Adds to S&P 500

Dow Jones
·
Jun 09

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-06-08

Reuters
·
Jun 08

Alnylam Pharmaceuticals Price Target Maintained With a $510.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 05

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Fractyl Health, Inc. (GUTS)

TIPRANKS
·
Jun 05

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-06-04

Reuters
·
Jun 04